Navigation Links
AMRI Appoints Michael Nolan Vice President, Chief Financial Officer and Treasurer
Date:9/12/2012

ALBANY, N.Y., Sept. 12, 2012 /PRNewswire/ -- Albany Molecular Research Inc. (Nasdaq: AMRI) today announced the appointment of Michael Nolan as Vice President, Chief Financial Officer and Treasurer of AMRI, succeeding Mark Frost, effective September 17, 2012.

(Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO )

Mr. Nolan was most recently Vice President, Finance, Financial Planning and Analysis at the Delaware North Companies, headquartered in Buffalo, N.Y. From 2009 through early 2012, Mr. Nolan was Vice President, Finance, Analytical Instruments Group at Thermo Fisher Scientific, Inc. where he was responsible for the global financial operations of a portfolio with revenue of $3 billion operating across three divisions with 15 business units, 41 plant sites and 9,700 employees. Prior to Thermo Fisher Scientific, Mr. Nolan held positions of increasing responsibility at ALCAN, which was later acquired by Rio Tinto Plc. While at Rio Tinto Plc., Mr. Nolan was accountable for leading the integration of 13 global ALCAN and Rio Tinto Plc. functions, including legal, company secretarial, business development and all finance functions including both the corporate and business teams. Mr. Nolan began his career in 1989 at E.I. du Pont de Nemours Company and received his MBA from The University of Windsor and a B.A. in Economics from The University of Western Ontario.

"I would like to thank Mark for his considerable contributions to AMRI in the almost eight years he has spent with the Company," said Thomas D'Ambra, Ph.D., AMRI's Chairman, President and Chief Executive Officer. "He was instrumental in building the Company's global reach as we expanded through both acquisitions and internal growth during his tenure. We wish him well in all his future endeavors and have established a plan to ensure a seamless transition to our new CFO."

D'Ambra continued, "The Board of Directors and I are pleased to welcome Mike to AMRI. He has had considerable experience in the business of science as well as overseeing the operational and finance requirements of a global business. We have made solid progress in reducing our cost structure, and increasing our marketing efforts as we roll out our new SMARTSOURCING™ initiative. Mike's strategic leadership, financial expertise and strong global experience will further support these initiatives and help us realize our plan for future growth and profitability."

About AMRI  
Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. For over 21 years AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development. For press releases and additional information about the company, please visit www.amriglobal.com.


'/>"/>
SOURCE AMRI
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Insmed Appoints Will Lewis as President and Chief Executive Officer
2. Circassia Appoints Dr Brett Haumann as Chief Medical Officer
3. Kinex Pharmaceuticals Appoints Mr. Patrick Gallagher Vice President of Business Development and Investor Relations
4. Islet Sciences Appoints Dr. Kevan Herold and Dr. Morton Printz to Scientific Advisory Board
5. Ameritox Appoints New CEO, Scott Walton
6. Cell Therapeutics, Inc. (CTI) Appoints Former Managing Director, Head of West Coast Biotechnology for Oppenheimer/CIBC Matthew J. Plunkett Executive Vice President, Corporate Development
7. IRIDEX Appoints Chairman William M. Moore as Interim President & CEO
8. Landauer, Inc. Appoints Ronald Zilkowski To Vice President, Corporate Controller And Chief Accounting Officer
9. Henry Schein Appoints Carol Raphael to Board of Directors
10. Kaiser Permanente Appoints Alexandra Morehouse as Vice President of Advertising and Brand Management
11. Accelr8 Appoints Steve Reichling Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
(Date:4/18/2017)... April 18, 2017  Cardinal Health (NYSE: ... fiscal 2017 earnings per share (EPS) guidance and providing ... is in conjunction with this morning,s announcement of the ... and Nutritional Insufficiency businesses. Cardinal Health now ... will be at the bottom of its previous guidance ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... ... B. Chaudhary, MD is committed to providing the highest quality of spine care to all ... care with all my patients to alleviate possible future issues. I am pleased to have ... office and my trained staff will assist you in any way possible.” , Dr. Saad ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... solutions, announces the continuation of its strategic partnership with and platinum sponsorship of ... nations in the safe and effective management of complex spine deformity cases, particularly ...
(Date:4/24/2017)... ... April 24, 2017 , ... Ridgecrest Herbals makes it a point to ... to reduce waste, and support renewable energy. They believe this is a crucial part ... find solutions for health issues, and maintain that destroying the environment in the pursuit ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... The California ... million in charitable dental services to 1,961 people during the April 22-23 event at ... no charge to Californians who experience barriers to care, CDA Cares educates the public ...
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class designers of Happy ... their novel lifesaving device for the everyday use of parents worldwide. It is ... to read a child’s vital signs, and detect unusual symptoms or physical patterns. ...
Breaking Medicine News(10 mins):